How much funding has Accutar Biotech raised?

Accutar Biotech has raised $28.0M in total funding, most recently a Series B round.

Who are Accutar Biotech's investors?

Accutar Biotech's investors include Yunfeng Capital, Coatue Management.

When was Accutar Biotech founded?

Accutar Biotech was founded in 2015.

Where is Accutar Biotech headquartered?

Accutar Biotech is headquartered in New York, United States.

What industry is Accutar Biotech in?

Accutar Biotech operates in Artificial Intelligence, Biotech, Healthcare.

How many employees does Accutar Biotech have?

Accutar Biotech has 11-50 employees.

Accutar Biotech

New York, United States · Founded 2015 · $28.0M raised

Artificial Intelligence

Biotech

Healthcare

Headquarters: New York
Employees: 11–50
Founded: 2015
Business Model: B2B

Website: accutarbio.com
Total Funding: $28.0M
Last Round: $28.0M Series BApr 2021
Rounds: 2

About

Accutar Biotech is a clinical-stage, AI-empowered drug discovery company headquartered in Brooklyn, New York, founded in 2015 by CEO Jie Fan. The company applies deep learning and computational chemistry to explain the physical and chemical nature of biological systems, powering a pipeline of small-molecule and targeted protein degradation programs, including AC0682, which is in Phase 1 trials for ER-positive breast cancer.

Summary

Accutar Biotech is an Artificial Intelligence company based in New York, United States, founded in 2015. It has raised $28.0M in total across 2 rounds, most recently a $28.0M Series B round in Apr 2021. Investors include Yunfeng Capital and Coatue Management.